| |
|
|
|
Akari Therapeutics Plc  
|
|
2.3623 -0.048 (-0.02%) |
05-23 13:23 |
|
Open: |
2.39 |
Pre close: |
2.41 |
Target:
|
4.68 
|
|
High: |
2.4493 |
Low: |
2.34 |
Resistance:
|
4.01
5.04
|
|
Volume: |
43,221 |
Market Cap: |
37M |
Support:
|
2.34
1.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.55
|
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
3.17 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
2.71  |
Stochastic Oscillator |
%K(14,3):
|
1.56 |
|
MA(250): |
2.24 |
%D(3): |
1.05 |
|
Average Volume(K) |
3-Month: |
258345
|
52-Week |
High:
|
9.20 |
|
10-Days: |
9268 |
Low: |
1.56 |
|
RSI |
RSI(14):
|
28.70 |
Change(%): |
32.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-168.6 |
Shares Out. (M) |
15.86 |
|
EPS Est. Current Year |
-2.360 |
Return on Assets (ttm) |
-91.9 |
Shares Float (M) |
14.54 |
|
EPS Est. Next Year |
-3.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.660 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.10 |
|
Forward EPS |
-1.938 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
14.980 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-20.73 |
P/CF |
-1.69 |
|
|
|
|
|
|
